- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin and cancer: licence to heal?
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 19, Issue 8, Pages 913-917
Publisher
Informa Healthcare
Online
2010-06-18
DOI
10.1517/13543784.2010.499122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin
- (2010) Piotr J Wysocki et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Metformin inhibits inflammatory angiogenesis in a murine sponge model
- (2009) D.O. Xavier et al. BIOMEDICINE & PHARMACOTHERAPY
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
- (2009) Jonathan L. Wright et al. CANCER CAUSES & CONTROL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration
- (2009) Kerstin Lang et al. Cell Communication and Signaling
- Does diabetes therapy influence the risk of cancer?
- (2009) U. Smith et al. DIABETOLOGIA
- Mitogenic action of insulin: friend, foe or ‘frenemy’?
- (2009) B. Draznin DIABETOLOGIA
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Metformin: diamonds are forever
- (2009) N Papanas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Do Diabetes Drugs Modify the Risk of Pancreatic Cancer?
- (2009) Yu–Xiao Yang GASTROENTEROLOGY
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
- Metformin As an Addition to Conventional Chemotherapy in Breast Cancer
- (2009) Tal Grenader et al. JOURNAL OF CLINICAL ONCOLOGY
- If Mammalian Target of Metformin Indirectly Is Mammalian Target of Rapamycin, Then the Insulin-Like Growth Factor-1 Receptor Axis Will Audit the Efficacy of Metformin in Cancer Clinical Trials
- (2009) Alejandro Vazquez-Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in Breast Cancer: Time for Action
- (2009) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhancing CD8 T-cell memory by modulating fatty acid metabolism
- (2009) Erika L. Pearce et al. NATURE
- Sulphonylureas and cancer: a case–control study
- (2008) Matteo Monami et al. ACTA DIABETOLOGICA
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
- (2008) Xu Huang et al. BIOCHEMICAL JOURNAL
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
- (2008) M. Zakikhani et al. Cancer Prevention Research
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Obesity and cancer
- (2008) Tobias Pischon et al. PROCEEDINGS OF THE NUTRITION SOCIETY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started